Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ F!omkN
G.W !
£¨ÃâÒßѧרҵºÍרҵ»ù´¡£© .|UQ)J?s
hx;f/EPx
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© V>Wk\'h
$NXP)Lic)
1.Co-stimulators (or co-stimulating molecules) Swi#^i
"LMj,qZ1!
2.NK-kB ZO0 Ee1/
?^}30V:E
3.Immunoglobulin superfamily %bW_,b
2eT?qCxqc
4.antigen-presenting cell (APC) 'D\Q$q
(i1JRn-
f
5.death domain jlEz]@
i
7s9h:/Lu
6.CCR and CXCR Vz{+3vfra6
d=!:UB
7.Lectin (or mitogen) +6m.f,14q
N.F5)04
8.Clusters of differentiation, CD) 7R+(3NU1A
G#M)5'Q]U
9.B7 family !40>LpL[
nB[-KS
10.Cytotoxic T lymphocyte, CTL) k9|5TLXq?
jN=<dq
~
11.IL-15 and IL-15 receptor (IL-15R) tYS4"Nfb+
+n3I\7G>
12.MHC restriction W:w~ M'o
rr<E#w
13.Affinity-chromatography bp1AN9~
8xpplo8
14.Cyctosprin A, CsA "tK%]c d-
9
_d2u#
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) *Ak .KBg
md!6@)S-p
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£©
;"3B,Yj
s6H'}[E<
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 |(7}0]BP0
_n&Nw7d2
M
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ !
> UlvT-
$YYWpeW
'
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£ _IH" SVub
?J[3_!"t
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© }5 o?7}?
;*K4{wvG
ÃâÒßѧרҵ£º MB plhVK8
1MelHW
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ >rG>Bz^Pu
9&Y@g)+2
Ïû»¯ÄÚ¿Æ£º :yay:3qv
Fu7:4+
2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ 5*0zI\
[^H2'&
]
ѪҺ²¡Ñ§×¨Òµ£º Et>#&Nw8
)7q$Pc
Y
3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿